glp-1 news november 2025 today New oral drug delivers up to 12% weight loss in 36 weeks GLP-1 Therapies May Benefit MPN

Dosierungen in Tierstudien: In der berwiegenden Mehrheit der prklinischen Studien lagen die bei der Ratte verwendeten Dosen zwischen 10 g/kg und 10 ng/kg Krpergewicht, verabreicht intraperitoneal oder oral

Current research provides reassurance: No evidence shows that GLP-1 therapy directly reduces testosterone levels

The clinical anatomy of endometriosis: a review

Photograph these documents and store them digitally as backup.

However, our analysis shows that people tend to regain weight rapidly after stopping faster than we see with behavioural programmes,' says lead author Dr Sam West, postdoctoral researcher at the Nuffield Department of Primary Care Health Sciences, University of Oxford